The global Rituxan (Rituximab) and Biosimilar market was valued at US$ 4244.4 million in 2022 and is projected to reach US$ 5345.4 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War we…Read More>>
The global Orally Disintegrating Drug market was valued at US$ 2013.7 million in 2022 and is projected to reach US$ 3702.7 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were consi…Read More>>
The global Thyrogen and Biosimilar market was valued at US$ 264.4 million in 2022 and is projected to reach US$ 703.3 million by 2029, at a CAGR of 15.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considere…Read More>>
The global Veterinary Health Diagnostics market was valued at US$ 3243.3 million in 2022 and is projected to reach US$ 4674 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were cons…Read More>>
The global Trastuzumab Monoclonal Antibody market was valued at US$ 4642.6 million in 2022 and is projected to reach US$ 6357.7 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were …Read More>>
The global Motion Sickness Pills market was valued at US$ 878.7 million in 2022 and is projected to reach US$ 1078.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered …Read More>>
The global Lentivirus Particle market was valued at US$ 287.1 million in 2022 and is projected to reach US$ 380.7 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered whi…Read More>>
The global Site-directed Mutagenesis Kit market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while es…Read More>>
The global Custom Antibody Development Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered wh…Read More>>
The global Inhibitor Screening Assay Kit market was valued at US$ 598.8 million in 2022 and is projected to reach US$ 846.7 million by 2029, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were cons…Read More>>
